This grant offered by the National Cancer Institute aims to accelerate cancer research through the Beau Biden Cancer MoonshotSM Initiative. The focus is on immunotherapy approaches for treating and preventing adult cancers, as identified by scientific priorities. The grant supports collaborative team science efforts to discover new immune targets and assess innovative immune-based therapies to eliminate established cancers or prevent new ones. Specifically, it establishes Cancer Immunoprevention Research Projects within a Cancer Immunotherapy Consortium, fostering translational research on immune mechanisms in tumor development and progression. Pre-clinical studies with potential for early-phase clinical applications are encouraged. Closing date for applications is Feb 8, 2019.
Opportunity ID: 310038
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CA-19-014 |
Funding Opportunity Title: | Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Environment Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.113 — Environmental Health |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Oct 31, 2018 |
Last Updated Date: | Oct 31, 2018 |
Original Closing Date for Applications: | Feb 08, 2019 |
Current Closing Date for Applications: | Feb 08, 2019 |
Archive Date: | Mar 16, 2019 |
Estimated Total Program Funding: | $3,400,000 |
Award Ceiling: | $500,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education State governments Public housing authorities/Indian housing authorities Independent school districts City or township governments Private institutions of higher education Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. Specifically, this FOA targets the following area designated as scientific priority by the Blue Ribbon Panel (BRP): Recommendation B. Create a translational science network devoted exclusively to immunotherapy approaches to treat and prevent adult cancers. The goal of the network is to foster collaborative team science approaches to accelerate the discovery of new immune targets and evaluate novel immune-based therapies and combination approaches that eliminate established cancers in adults or to prevent cancers before they occur. The purpose of this specific FOA is to establish Cancer Immunoprevention Research Projects that will function as components of a Cancer Immunotherapy Consortium (CIC), which will also include Cancer Immunotherapy Research Projects. The CIC will form an integrated network of multi-disciplinary, collaborative teams with the overarching goals of accelerating translational research of innate and adaptive immune mechanisms that contribute to tumor initiation and progression, and evaluating new or improved immunopreventive and immunotherapeutic strategies (including combinations with standard or other therapies). Studies should be largely pre-clinical involving clinically-relevant models and endpoints, and have the potential for rapid translation into early-phase clinical applications. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-014.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | FORMS-E | PKG00246005 | Jan 08, 2019 | Feb 08, 2019 | View |
Package 1
Mandatory forms
310038 RR_SF424_2_0-2.0.pdf
310038 PHS398_CoverPageSupplement_4_0-4.0.pdf
310038 RR_OtherProjectInfo_1_4-1.4.pdf
310038 PerformanceSite_2_0-2.0.pdf
310038 RR_KeyPersonExpanded_2_0-2.0.pdf
310038 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
310038 RR_Budget_1_4-1.4.pdf
310038 RR_SubawardBudget30_1_4-1.4.pdf
310038 PHS398_ModularBudget_1_2-1.2.pdf
310038 PHS_AssignmentRequestForm_2_0-2.0.pdf